Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03003676
Brief Title: A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

First Submitted : December 19, 2016
First Submitted that Met QC Criteria : December 21, 2016
First Posted : December 28, 2016 (Estimate)

Results First Submitted : July 16, 2021
Results First Submitted that Met QC Criteria : July 16, 2021
Results First Posted : August 9, 2021

Last Update Submitted that Met QC Criteria : October 11, 2021
Last Update Posted : November 8, 2021